Human T cell receptor-mediated recognition of HLA-E

European Journal of Immunology

Volumn 32, Issue 4, 2002, Pages 936-944

  García, Pilar ^a   Llano, Manuel ^a,d   De Heredia, Agustín B ^a   Willberg, Christian B ^c   Caparrós, Esther ^a   Aparicio, Pedro ^b   Braud, Véronique M ^a,e   López Botet, Miguel ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d MAYO CLINIC   (United States)

^e CNRS   (France)

Author keywords

CTL; Cytotoxicity; MHC; TCR

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; CD94 ANTIGEN; HLA ANTIGEN CLASS 1; HLA E ANTIGEN; LATENT MEMBRANE PROTEIN 1; LECTIN RECEPTOR; MONOCLONAL ANTIBODY; PEPTIDE; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; LYMPHOCYTE CLONE; NATURAL KILLER CELL; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, VIRAL; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; BIOPOLYMERS; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; PEPTIDE FRAGMENTS; PROTEIN SORTING SIGNALS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATORS; TRANSFECTION; VIRAL PROTEINS;

EID: 0036234999     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO;2-M     Document Type: Article

References (42)

1. Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism
2. HLA-E. A novel HLA class I gene expressed in resting T lymphocytes
3. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
4. The human major histocompatibility complex class lb molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
5. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
6. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
8. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
9. Human NK-cell receptors
10. Paired inhibitory and triggering NK cell receptors for HLA class I molecules
11. Turning on natural killer cells
12. HLA class I recognition by killer cell Ig-like receptors
13. Development and tolerance of natural killer cells
14. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)
15. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes
16. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen
17. Qa-1b binds conserved class I leader peptides derived from several mammalian species
18. Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class lb-restricted antilisterial cytotoxic T lymphocytes
19. + T cells
20. Analysis of T cell receptors specific for recognition of class IB antigens
21. Molecular mimicry mediated by MHC class Ib molecules after infection with Gram-negative pathogens
22. + T cells restricted by the MHC class Ib molecule, Qa-1
23. Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation
24. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
25. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice
26. Cutting edge: Requirement of class I signal sequence-derived peptides for HLA-E recognition by a mouse cytotoxic T cell clone
27. + CTLs by TCR Vβ-derived peptides bound to HLA-E
28. + T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer
29. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
30. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
31. Specificity and degeneracy in antigen recognition: Yin and yang in the immune system
32. Cell surface expression of HLA-E: Interaction with human beta2- microglobulin and allelic differences
33. Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells
34. Structural features impose tight peptide binding specificity in the non-classical MHC molecule HLA-E
35. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
36. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
37. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
38. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis
39. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia
40. Association of DAP12 with activating CD94/NKG2C NK cell receptors
41. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen
42. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules